Relationship between the exocrine and endocrine pancreas after acute pancreatitis

Table 1 Baseline characteristics of patients in included studies

Ref.	No. of patients	Sex		Age	Aetiology			Time to follow up (mo)
		Male	Female		Biliary	Alcohol	Other
Andersson et al[14]	41	16	25	61 (48-68)1	20	10	11	42 (36-53)1
Angelini et al[15]	27	24	3	Not Stated	10	11	6	12-60
Bavare et al[16]	18	18	0	36 (25-47)1	4	10	4	12-18
Endlicher et al[17]	9	5	4	44 (19-69)1	4	2	3	30 (15-52)2
Gupta et al[18]	30	24	6	37.5 (14-65)2	12	10	8	31.3 (7-118)2
Hochman et al[19]	25	16	9	58.8 (37-86)2	11	4	10	24-36
Tsiotos et al[20]	44	33	11	58 (20-93)2	17	5	22	60 (3-132)2
Uomo et al[21]	40	17	23	48.4 ± 18.23	28	0	12	179 (156-203)1
Total	234	153	81		106	52	76

¹Median (range);

²Mean (range);

³Mean ± SD.

Table 2 Summary of quality assessment using the Newcastle-Ottawa scale

Ref.	Selection	Comparability	Outcome	Total
Andersson et al[14]	3	2	3	8
Angelini et al[15]	2	1	3	6
Bavare et al[16]	2	2	3	7
Endlicher et al[17]	2	1	3	6
Gupta et al[18]	3	2	3	8
Hochman et al[19]	3	2	3	8
Tsiotos et al[20]	2	1	3	6
Uomo et al[21]	2	1	3	6
Mean	2	2	3	7

Table 3 Study outcomes

Ref.	No. of patients	No. with prediabetes or diabetes (%)	Total1	No. with pancreatitic exocrine insufficiency (%)	Total1	Concomitant insufficiency (%)	Total1
Andersson et al[14]	41	24 (58.5)	41	9 (22.0)	41	6 (14.6)	41
Angelini et al[15]	27	9 (47.4)	19	1 (7.1)	14	1 (7.1)	14
Bavare et al[16]	18	13 (72.2)	18	5 (27.8)	18	5 (27.8)	18
Endlicher et al[17]	9	3 (50.0)	6	7 (87.5)	8	3 (60.0)	5
Gupta et al[18]	30	12 (40.0)	30	12 (40.0)	30	8 (26.7)	30
Hochman et al[19]	25	8 (32.0)	25	5 (20.0)	25	2 (8.0)	25
Tsiotos et al[20]	44	16 (36.4)	44	11 (25.0)	44	5 (11.4)	44
Uomo et al[21]	40	6 (15.8)	38	9 (22.5)	40	3 (7.9)	38
Total	234	91 (41.2)	221	59 (26.8)	220	33 (15.3)	215

¹Patients with adequate data available to calculate the outcome.